Invited letter MUC4 mutations as an amplifier of complement‐mediated thrombosis in paroxysmal nocturnal haemoglobinuria

Documenti analoghi

• MUC4 mutations promote a thrombotic phenotype in patients with paroxysmal nocturnal haemoglobinuria by increasing the deposition of terminal complement
  di: Yingying Chen, et al.
  Pubblicazione: (2026)
• Anti‐PF4 antibody inhibit proliferation of lung cancer cells without TP53 mutation by inducing apoptosis and cell cycle arrest
  di: Mengjia Qian, et al.
  Pubblicazione: (2025)
• A new member at the table: Granzyme K as a lymphocyte‐born complement initiator
  di: Manoj Kumar Pandey
  Pubblicazione: (2025)
• Targeting mutated KRAS in the first‐line therapy
  di: Hideaki Ijichi
  Pubblicazione: (2024)
• Precision treatment paradigm: Genomic features and therapeutic implications in mesenchymal‐epithelial transition‐amplified gastric cancer
  di: Yiyi Yu, et al.
  Pubblicazione: (2024)